Market Cap 55.54B
Revenue (ttm) 21.84B
Net Income (ttm) 1.68B
EPS (ttm) N/A
PE Ratio 13.46
Forward PE 13.07
Profit Margin 7.68%
Debt to Equity Ratio 0.69
Volume 1,363,800
Avg Vol 2,295,416
Day's Range N/A - N/A
Shares Out 284.91M
Stochastic %K 44%
Beta 0.23
Analysts Sell
Price Target $201.70

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 847 6800
Website: www.bd.com
Address:
1 Becton Drive, Franklin Lakes, United States
TrendDecoded
TrendDecoded Jan. 5 at 11:20 AM
$MU $VLO $FCX $BDX $SLB The market winds have decisively shifted in favor of the bulls.
0 · Reply
EliteStockTrader
EliteStockTrader Jan. 2 at 3:03 PM
$BDX Current Price & Change: $194.11 (+0.02%) Trend Indicator: Bullish RSI Level: 26.9 Volume Activity: -96.3% vs avg Volatility: 1.38% Price Target: $194.13 Confidence: 85% I do not provide personalized financial advice or sell premium subscriptions. Any communication requesting payment for services is unauthorized. My only official outlet is https://stocksecret.news Always conduct your own due diligence.
0 · Reply
11thestate
11thestate Jan. 2 at 3:03 PM
If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $BDX — how you can actually recover something: https://11th.com/cases/bdx-shareholder-settlement
0 · Reply
TalkMarkets
TalkMarkets Jan. 2 at 12:15 PM
Dividend Stock Analysis - Becton, Dickinson And Co. $BDX https://talkmarkets.com/content/stocks--equities/dividend-stock-analysis-becton-dickinson-and-co?post=547929&userid=166882
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Jan. 1 at 5:16 PM
$BDX Significant decrease in volume compared to average volume. Price has been relatively stable around $195 levels with no major price movements. Waiting for a lower H% before considering any entry.
0 · Reply
TalkMarkets
TalkMarkets Jan. 1 at 1:44 PM
10 Best Dividend Stocks For 2026 $BRO $LAD $THG $BDX $SON https://talkmarkets.com/content/stocks--equities/10-best-dividend-stocks-for-2026?post=547774&userid=166882
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 25 at 11:09 PM
$BDX Current Stock Price: $196.38 Contracts to trade: $195 BDX Jan 16 2026 Call Entry: $4.00 Exit: $5.21 ROI: 30% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MatrixMoverV2
MatrixMoverV2 Dec. 24 at 6:36 PM
$BDX Downside protection weakens if whether reinvestment choices generate durable competitive insulation, with outcomes shaped by timing and discipline. Uncertainty remains until results confirm narrative.
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 5:49 PM
$BDX teams up with Penn — quiet move, big implications for immunotherapy? 🧬 BD and the Penn Institute for Immunology and Immune Health are launching a high-parameter immune profiling study aimed at advancing immunotherapy research. Discover why this collaboration could matter for BD 👉 https://www.zacks.com/stock/news/2807575/bd-and-penn-institute-ink-collaboration-to-advance-immunotherapy?cid=sm-stocktwits-2-2807575-teaser-25886&ADID=SYND_STOCKTWITS_TWEET_2_2807575_TEASER_25886
0 · Reply
SparkyReturns
SparkyReturns Dec. 22 at 5:21 PM
$ICU Dammit I should keep quiet. Now I gotta chase it to get more shares. This device will be a game-changer for kidney disease, sepsis, cardio-renal, and any disease with hyper-inflammation and cytokine storm. GL longs! $DVA $BAX $MCK $BDX
0 · Reply
Latest News on BDX
Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 4 days ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR


Best Dividend Kings: December 2025

Dec 28, 2025, 6:44 AM EST - 7 days ago

Best Dividend Kings: December 2025

ABBV ABM ABT ADM ADP AWR BKH


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 5 weeks ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR


BD Board Increases Dividend for 54th Consecutive Year

Nov 6, 2025, 6:25 AM EST - 2 months ago

BD Board Increases Dividend for 54th Consecutive Year


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 2 months ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 2 months ago

Best Dividend Kings: October 2025

ABBV ABM ABT ADM ADP AWR BKH


Becton Dickinson's CFO to depart

Oct 15, 2025, 4:42 PM EDT - 2 months ago

Becton Dickinson's CFO to depart


BD Announces CFO Transition Plan

Oct 15, 2025, 4:15 PM EDT - 2 months ago

BD Announces CFO Transition Plan


Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 3 months ago

Best Dividend Aristocrats For October 2025

ABT ADP ATO BEN CAH CHRW CL


Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 4 months ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR


Best Dividend Kings: August 2025

Aug 24, 2025, 10:13 PM EDT - 4 months ago

Best Dividend Kings: August 2025

ABBV ABM ABT ADM AWR BKH CINF


Becton, Dickinson: Great Time To Buy This Dividend Aristocrat

Aug 18, 2025, 8:00 AM EDT - 4 months ago

Becton, Dickinson: Great Time To Buy This Dividend Aristocrat


BD to Present at Wells Fargo 2025 Healthcare Conference

Aug 14, 2025, 4:15 PM EDT - 5 months ago

BD to Present at Wells Fargo 2025 Healthcare Conference


Becton Dickinson Q3 Beats Estimates On Medical Device Boom

Aug 7, 2025, 11:40 AM EDT - 5 months ago

Becton Dickinson Q3 Beats Estimates On Medical Device Boom


TrendDecoded
TrendDecoded Jan. 5 at 11:20 AM
$MU $VLO $FCX $BDX $SLB The market winds have decisively shifted in favor of the bulls.
0 · Reply
EliteStockTrader
EliteStockTrader Jan. 2 at 3:03 PM
$BDX Current Price & Change: $194.11 (+0.02%) Trend Indicator: Bullish RSI Level: 26.9 Volume Activity: -96.3% vs avg Volatility: 1.38% Price Target: $194.13 Confidence: 85% I do not provide personalized financial advice or sell premium subscriptions. Any communication requesting payment for services is unauthorized. My only official outlet is https://stocksecret.news Always conduct your own due diligence.
0 · Reply
11thestate
11thestate Jan. 2 at 3:03 PM
If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $BDX — how you can actually recover something: https://11th.com/cases/bdx-shareholder-settlement
0 · Reply
TalkMarkets
TalkMarkets Jan. 2 at 12:15 PM
Dividend Stock Analysis - Becton, Dickinson And Co. $BDX https://talkmarkets.com/content/stocks--equities/dividend-stock-analysis-becton-dickinson-and-co?post=547929&userid=166882
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Jan. 1 at 5:16 PM
$BDX Significant decrease in volume compared to average volume. Price has been relatively stable around $195 levels with no major price movements. Waiting for a lower H% before considering any entry.
0 · Reply
TalkMarkets
TalkMarkets Jan. 1 at 1:44 PM
10 Best Dividend Stocks For 2026 $BRO $LAD $THG $BDX $SON https://talkmarkets.com/content/stocks--equities/10-best-dividend-stocks-for-2026?post=547774&userid=166882
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 25 at 11:09 PM
$BDX Current Stock Price: $196.38 Contracts to trade: $195 BDX Jan 16 2026 Call Entry: $4.00 Exit: $5.21 ROI: 30% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MatrixMoverV2
MatrixMoverV2 Dec. 24 at 6:36 PM
$BDX Downside protection weakens if whether reinvestment choices generate durable competitive insulation, with outcomes shaped by timing and discipline. Uncertainty remains until results confirm narrative.
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 5:49 PM
$BDX teams up with Penn — quiet move, big implications for immunotherapy? 🧬 BD and the Penn Institute for Immunology and Immune Health are launching a high-parameter immune profiling study aimed at advancing immunotherapy research. Discover why this collaboration could matter for BD 👉 https://www.zacks.com/stock/news/2807575/bd-and-penn-institute-ink-collaboration-to-advance-immunotherapy?cid=sm-stocktwits-2-2807575-teaser-25886&ADID=SYND_STOCKTWITS_TWEET_2_2807575_TEASER_25886
0 · Reply
SparkyReturns
SparkyReturns Dec. 22 at 5:21 PM
$ICU Dammit I should keep quiet. Now I gotta chase it to get more shares. This device will be a game-changer for kidney disease, sepsis, cardio-renal, and any disease with hyper-inflammation and cytokine storm. GL longs! $DVA $BAX $MCK $BDX
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 4:49 PM
$BDX just teamed up with Penn’s I3H — what it means for the planned immune profiling study 🚀 The partnership aims to analyze cellular functions with the BD FACSDiscover A8 Cell Analyzer, potentially enhancing BD's competitive edge in immunotherapy markets. Discover the full impact here 👉 https://www.zacks.com/stock/news/2807575/bd-and-penn-institute-ink-collaboration-to-advance-immunotherapy?cid=sm-stocktwits-2-2807575-body-25852&ADID=SYND_STOCKTWITS_TWEET_2_2807575_BODY_25852
0 · Reply
11thestate
11thestate Dec. 19 at 4:53 PM
Imagine buying $BDX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $BDX investors out there, we’ve got some important news for you: https://11th.com/cases/bdx-shareholder-settlement
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:06 PM
RBC Capital has updated their rating for Becton Dickinson ( $BDX ) to Sector Perform with a price target of 210.
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 5:21 PM
$BDX just strengthened its diagnostics moat in Europe — here’s why it matters 🧪 BD expanded its BD MAX menu with IVDR-approved VIASURE respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy across Europe. Discover how this expansion supports BDX’s long-term diagnostics push 👉 https://www.zacks.com/stock/news/2805137/bd-expands-bd-max-with-ivdr-approved-viasure-tests-in-europe?cid=sm-stocktwits-2-2805137-teaser-25098&ADID=SYND_STOCKTWITS_TWEET_2_2805137_TEASER_25098
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 4:21 PM
$BDX expands its diagnostics portfolio in Europe — shares dip 0.4% following the news. 🤔 The IVDR-certified tests for the BD MAX System aim to boost its competitive edge in molecular diagnostics. Over the past 6 months, BDX has outperformed its industry and the S&P 500, climbing 16.3%. Discover the deeper dynamics at play here 👉 https://www.zacks.com/stock/news/2805137/bd-expands-bd-max-with-ivdr-approved-viasure-tests-in-europe?cid=sm-stocktwits-2-2805137-body-25045&ADID=SYND_STOCKTWITS_TWEET_2_2805137_BODY_25045
0 · Reply
Estimize
Estimize Dec. 15 at 1:03 PM
Wall St is expecting 2.81 EPS for $BDX Q1 [Reporting 01/29 AMC] http://www.estimize.com/intro/bdx?chart=historical&metric_name=eps&utm_cont
0 · Reply
OptionRunners
OptionRunners Dec. 10 at 6:21 PM
$BDX flying today. These calls doubled
0 · Reply
Thricejp1
Thricejp1 Dec. 10 at 5:35 PM
$BDX yep
0 · Reply
IP4you
IP4you Dec. 10 at 5:10 PM
$BDX target still is 220 by February - upgrades, company is doing buy backs and dust settling on some litigation. Rate cuts should help too.
0 · Reply
Palantir500
Palantir500 Dec. 10 at 4:42 PM
$BDX Nice move today!!
0 · Reply
RonIsWrong
RonIsWrong Dec. 10 at 4:20 PM
$BDX I averaged down a little on those calls yesterday. working out. But I'm looking for a breakout move. Today: Jefferies Adjusts PT on Becton, Dickinson and Co. to $220 From $215, Maintains Buy Rating
1 · Reply
11thestate
11thestate Dec. 9 at 6:10 PM
$BDX has agreed to settle for $85M to resolve claims that it misled investors about safety and software issues affecting its Alaris infusion pump system. Who’s eligible? Anyone who purchased $BDX shares between November 5, 2019 and February 5, 2020. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $2.14 — but if only ~25% of eligible investors file, the effective payout could increase to $8.56. Can I still file? Yes — late claims are currently being accepted, subject to approval. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/bdx-shareholder-settlement
0 · Reply